期刊文献+

恶性黑素瘤中端粒酶表达的意义

下载PDF
导出
摘要 端粒存在于染色体的末端 ,端粒酶是一种由RNA和蛋白质组成的核糖核蛋白 ,能以自身RNA为模板不断合成端粒 ,与细胞的永生化、癌变有关。端粒酶在恶性黑素瘤的发生发展过程中具有重要作用 ,为恶性黑素瘤的早期诊断。
机构地区 中国医学科学院
出处 《国外医学(皮肤性病学分册)》 2003年第3期180-182,共3页 Foreign Medical Sciences(Section of Dermatology and Venereology)
  • 相关文献

参考文献16

  • 1Greenberg RA, OHagan RC, Deng H, et al. Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation. Oncogene, 1999, 18 ( 5 ) : 1219 -1226.
  • 2Pathak S, Multani AS, McConkey D J, et al. Spontaneous regression of cutaneous melanoma in sinclair swine is associated with defective telomerase activity and extensive telomere erosion. Int J Oncol, 2000, 17(6) :1219 - 1224.
  • 3Avilion AA, Piatyszek MA, Gupta J, et al. Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res, 1996, 56(3) :645 -650.
  • 4Parris CN, Jezzard S, Silver A, et al. Telomerase activity in melanoma and non-melanoma skin cancer. Br J Cancer, 1999, 79( 1 ) :47 -53.
  • 5Dhaene K, Vancoillie G, Lambert J, et al. Absence of telomerase activity and telemorase catalytic subunit mRNA in melanocyte cultures.Br J Cancer, 2000, 82(5):1051 -1057.
  • 6Wynford-Thomas D. Cellular senescence and cancer. J Pathol, 1999,187(1):100-11.
  • 7Kyo S, Kanaya T, Takakura M, et al. Human telomerase reverse transcriptase as a critical determinant of telomerase activity in normal and malignant endometrial tissues. Int J Cancer, 1999, 80( 1 ) :60 -63.
  • 8Villa R, Porta CD, Folini M, et al. Possible regulation of telomerase activity by transcription and alternative splicing of telomerase reverse transcriptase in human melanoma. J Invest Dermatol, 2001, 116(6) :867 - 873.
  • 9Ayyoub M, Migliaccio M, Guillaume P, et al. Lack of tumor recognition by hTERT peptide 540 - 548 - specific CD8 ( + ) T cells from melanoma patients reveals inefficient antigen processing. Eur J Immunol, 2001, 31 (9) :2642 -2651.
  • 10Ramirez RD, D'Atri S, Pagani E, et al. Progressive increase in telomerase activity from benign melanocytic conditions to malignant melanoma. Neoplasia, 1999, 1 ( 1 ) :42 -49.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部